Synthobolic Extreme Synthol

Synthobolic Extreme Synthol – Guaranteed Size and Muscle Definition

Gone are the days when a great physique was a characteristic feature of people serving in the armed forces or sports persons or athletes. The modern world in a health conscious world where a physically fit body is considered to be one of the most valuable assets that a human being can possess or is Read more about Synthobolic Extreme Synthol – Guaranteed Size and Muscle Definition[…]

accumed international

AccuMed Terminates Agreement With CellMetrix

AccuMed International, Inc. has terminated the Patent and Technology License and Registration Rights Agreement with CellMetrix, Inc. All of the intellectual property, technology, and product rights licensed to CellMetrix have been returned to AccuMed. Additionally, Ampersand Medical Corporation recently signed a Letter of Intent to merge with and into AccuMed International, Inc. The Company intends Read more about AccuMed Terminates Agreement With CellMetrix[…]

glycodesign inc

GLYCODesign And Leo Signs Cardiovascular Collaboration

GLYCODesign Inc. (GD) has entered into a joint venture with Leo Pharmaceutical Products Ltd. (Leo) of Denmark to develop novel drug candidates for the treatment of selected cardiovascular diseases. During the initial three-year term of the collaboration, GD and Leo will combine their respective strengths in cardiovascular research and the manufacture of drugs based on Read more about GLYCODesign And Leo Signs Cardiovascular Collaboration[…]

glaucoma treatment device

Coronado Industries Signs Agreement For Glaucoma Treatment Device

Coronado Industries Inc., a manufacturer of pneumatic devices for the treatment of glaucoma, announced that the company has made a further major advance into the European markets by concluding a sales and distribution agreement with Izasa S.A. of Madrid, Spain. Izasa S.A. is a privately held company with more than 20 years experience in the Read more about Coronado Industries Signs Agreement For Glaucoma Treatment Device[…]

transax

Vega-Atlantic Corporation Announces Merger With Transax

Subject to final due diligence, and Board of Director and shareholder ratification, Vega-Atlantic is to merge with Transax, meaning that Transax will become a wholly-owned subsidiary of the Company. The Company’s business operations will then become the development, acquisition and marketing of leading information network solutions for healthcare providers and health insurance companies and other Read more about Vega-Atlantic Corporation Announces Merger With Transax[…]

Ortho-McNeil Pharmaceutical

Ortho-McNeil To Acquire U.S. Rights To AXERT

Ortho-McNeil Pharmaceutical, Inc. is to acquire the U.S. sales and marketing rights to AXERT (almotriptan malate) Tablets, pursuant to a licensing agreement with the drug’s innovator Almirall. AXERT is a prescription medication approved to treat migraine headaches in adults. Completion of the transaction, which is expected to occur during the second quarter of 2003, is Read more about Ortho-McNeil To Acquire U.S. Rights To AXERT[…]

Elixir Pharmaceuticals

Elixir And NHGRI Agree Genetic Collaboration

Elixir Pharmaceuticals is collaborating with researchers in Francis S. Collins’s laboratory at the National Human Genome Research Institute (NHGRI) and Dr. Michael Boehnke’s laboratory at the University of Michigan to study the relationship of the recently discovered Lamin A (LMNA) gene to the normal aging process.The NHGRI announced last week the discovery of the association Read more about Elixir And NHGRI Agree Genetic Collaboration[…]

abbott laboratories

Abbott Enters Agreement With Medical Analysis Systems

Abbott Laboratories has announced a co-marketing agreement with Medical Analysis Systems, Inc. (MAS), a Fisher Scientific International Inc. company, for the VecTest (TM) family of antigen-based assays, including a rapid test for detecting the West Nile virus in infected mosquitoes.The proprietary VecTest products, developed and manufactured by MAS, also include rapid tests for detecting malaria Read more about Abbott Enters Agreement With Medical Analysis Systems[…]

Aventis

Vivalis And Aventis Sign License Agreement

Aventis has announced the signing of a commercial research, option and license agreement with Vivalis in the field of avian stem cells. The two companies will combine the ALVAC canarypox virus platform of Aventis Pasteur, the vaccines business of Aventis, and Vivalis’ proprietary avian stem cell platform to enable Aventis Pasteur to improve the large-scale Read more about Vivalis And Aventis Sign License Agreement[…]

eos biotechnology

Eos Announces Termination Of Merger With Pharmacopeia

Eos Biotechnology, Inc. has announced that it will not proceed with plans to merge with Pharmacopeia, as was announced in August 2001. The two companies mutually agreed today not to proceed with the intended transaction. “Eos has the people, technology, partners and vision to build a leading therapeutic development company. We are currently focused on Read more about Eos Announces Termination Of Merger With Pharmacopeia[…]